-
1
Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma
Published 2025-03-01Subjects: Get full text
Article -
2
Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes
Published 2023-07-01Subjects: Get full text
Article